Literature DB >> 1549585

Increased permeability across the blood-nerve barrier of albumin glycated in vitro and in vivo from patients with diabetic polyneuropathy.

J F Poduslo1, G L Curran.   

Abstract

The blood-nerve transfer of human plasma albumin glycated with D-glucose was investigated by measuring the permeability coefficient-surface area product (PS) of the blood-nerve barrier to radioiodinated albumin in normal adult rat sciatic nerve. Human albumin (ALB) from normal individuals, freshly isolated by CM-Affi-Gel Blue affinity chromatography, was glycated in vitro for 1, 3, 10, 19, and 30 weeks. Glycated ALB (gALB) was separated from the nonglycated form by boronate-affinity chromatography. The efficiency of this separation was assessed by chromatography of ALB glycated with [14C]glucose and by rechromatography of isolated ALB and gALB after radioiodination. The gALB was also shown to have a higher molecular weight and be completely separated from ALB after SDS/pore gradient electrophoresis in a Tris borate/EDTA buffer. After 1 week of glycation, the gALB PS was 2.2-fold greater than the ALB PS (0.724 +/- 0.063 x 10(-6) vs. 0.328 +/- 0.053 x 10(-6) ml.g-1.s-1; mean +/- SD; P less than 0.0001) and it increased with the time of glycation reaching a maximum value of 16.2-fold greater at 30 weeks (4.656 +/- 1.117 x 10(-6) vs. 0.288 +/- 0.042 x 10(-6) ml.g-1.s-1; mean +/- SD; P less than 0.0001). No change was observed in the residual endoneurial plasma volume. In addition, the PS of gALB isolated from patients with diabetic polyneuropathy was significantly increased (P less than 0.0001) compared to the PS for ALB isolated from the same patients. It is hypothesized that the increased permeability of gALB and presumably other glycated serum components across the blood-nerve barrier, as well as the observed quantitative increase in ALB, IgG, and IgM in sural nerve biopsies from patients with diabetic polyneuropathy contribute to the development of diabetic polyneuropathy over a prolonged period of time by mechanisms that might involve osmotic changes in the nerve microenvironment, direct toxic effects of glycated macromolecules on cells within the endoneurium, or nerve damage by classical immunological mechanisms due to trapping of glycated immunoglobulins within nerve.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1549585      PMCID: PMC48628          DOI: 10.1073/pnas.89.6.2218

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  The distribution of serum albumin in rat peripheral nerve.

Authors:  M Mata; J Staple; D J Fink
Journal:  J Neuropathol Exp Neurol       Date:  1987-07       Impact factor: 3.685

2.  Decreased interaction of fibronectin, type IV collagen, and heparin due to nonenzymatic glycation. Implications for diabetes mellitus.

Authors:  J F Tarsio; L A Reger; L T Furcht
Journal:  Biochemistry       Date:  1987-02-24       Impact factor: 3.162

3.  Glycoprotein molecular-weight estimation using sodium dodecyl sulfate-pore gradient electrophoresis: comparison of tris-glycine and tris-borate-EDTA buffer systems.

Authors:  J F Poduslo
Journal:  Anal Biochem       Date:  1981-06       Impact factor: 3.365

4.  Nonenzymatic glucosylation of rat albumin. Studies in vitro and in vivo.

Authors:  J F Day; R W Thornburg; S R Thorpe; J W Baynes
Journal:  J Biol Chem       Date:  1979-10-10       Impact factor: 5.157

5.  Nonenzymatic glycosylation of low density lipoproteins in vitro. Effects on cell-interactive properties.

Authors:  B Gonen; J Baenziger; G Schonfeld; D Jacobson; P Farrar
Journal:  Diabetes       Date:  1981-10       Impact factor: 9.461

6.  Mammalian endoneurial fluid: collection and protein analysis from normal and crushed nerves.

Authors:  J F Poduslo; P A Low; K K Nickander; P J Dyck
Journal:  Brain Res       Date:  1985-04-15       Impact factor: 3.252

7.  Effects of age and diabetes mellitus on the solubility and nonenzymatic glucosylation of human skin collagen.

Authors:  S L Schnider; R R Kohn
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

8.  Glycation of platelet protein in diabetes mellitus: lack of correlation with platelet function.

Authors:  R W Yatscoff; A Mehta; J M Gerrard; J Thliveris
Journal:  Clin Biochem       Date:  1987-10       Impact factor: 3.281

9.  Glycation of very low density lipoprotein from rat plasma impairs its catabolism.

Authors:  J C Mamo; L Szeto; G Steiner
Journal:  Diabetologia       Date:  1990-06       Impact factor: 10.122

10.  Covalent attachment of soluble proteins by nonenzymatically glycosylated collagen. Role in the in situ formation of immune complexes.

Authors:  M Brownlee; S Pongor; A Cerami
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

View more
  20 in total

Review 1.  Development of neuropeptide drugs that cross the blood-brain barrier.

Authors:  Richard D Egleton; Thomas P Davis
Journal:  NeuroRx       Date:  2005-01

2.  Kinetics of K(+)-p-nitrophenyl phosphatase stimulation by a brain soluble fraction.

Authors:  G Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  1997-02       Impact factor: 3.996

3.  Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily.

Authors:  Angelika Bierhaus; Karl-Matthias Haslbeck; Per M Humpert; Birgit Liliensiek; Thomas Dehmer; Michael Morcos; Ahmed A R Sayed; Martin Andrassy; Stephan Schiekofer; Jochen G Schneider; Jörg B Schulz; Dieter Heuss; Bernhard Neundörfer; Stefan Dierl; Jochen Huber; Hans Tritschler; Ann-Marie Schmidt; Markus Schwaninger; Hans-Ulrich Haering; Erwin Schleicher; Michael Kasper; David M Stern; Bernd Arnold; Peter P Nawroth
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

4.  Triglyceride, nonesterified fatty acids, and prediabetic neuropathy: role for oxidative-nitrosative stress.

Authors:  Sergey Lupachyk; Pierre Watcho; Nailia Hasanova; Ulrich Julius; Irina G Obrosova
Journal:  Free Radic Biol Med       Date:  2012-02-04       Impact factor: 7.376

Review 5.  Agile delivery of protein therapeutics to CNS.

Authors:  Xiang Yi; Devika S Manickam; Anna Brynskikh; Alexander V Kabanov
Journal:  J Control Release       Date:  2014-06-21       Impact factor: 9.776

6.  Apolipoprotein A-I Crosses the Blood-Brain Barrier through Clathrin-Independent and Cholesterol-Mediated Endocytosis.

Authors:  Andrew L Zhou; Suresh K Swaminathan; Geoffry L Curran; Joseph F Poduslo; Val J Lowe; Ling Li; Karunya K Kandimalla
Journal:  J Pharmacol Exp Ther       Date:  2019-04-10       Impact factor: 4.030

Review 7.  The role of glycation in the pathogenesis of diabetic polyneuropathy.

Authors:  R H King
Journal:  Mol Pathol       Date:  2001-12

8.  Macromolecular permeability across the blood-nerve and blood-brain barriers.

Authors:  J F Poduslo; G L Curran; C T Berg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

9.  Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques.

Authors:  Joseph F Poduslo; Geoffry L Curran; Jane A Peterson; Daniel J McCormick; Abdul H Fauq; Murad A Khan; Thomas M Wengenack
Journal:  Biochemistry       Date:  2004-05-25       Impact factor: 3.162

10.  Electron microscopic immunocytochemical demonstration of blood-retinal barrier breakdown in human diabetics and its association with aldose reductase in retinal vascular endothelium and retinal pigment epithelium.

Authors:  S A Vinores; E Van Niel; J L Swerdloff; P A Campochiaro
Journal:  Histochem J       Date:  1993-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.